Gender and iron genes may modify associations between brain iron and memory in healthy aging

Neuropsychopharmacology

Volumn 36, Issue 7, 2011, Pages 1375-1384

  Bartzokis, George ^a,b,c   Lu, Po H ^a   Tingus, Kathleen ^a   Peters, Douglas G ^a,c   Amar, Chetan P ^a,c   Tishler, Todd A ^a,c   Finn, J Paul ^a   Villablanca, Pablo ^a   Altshuler, Lori L ^a   Mintz, Jim ^d   Neely, Elizabeth ^e   Connor, James R ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Division of Brain Mapping   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

dementia; gene; iron; memory; sex; treatment

Indexed keywords

FERRITIN; IRON;

ADULT; AGED; ARTICLE; ATTENTION; BASAL GANGLION; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GRAY MATTER; HIGH RISK POPULATION; HIPPOCAMPUS; HUMAN; IN VIVO STUDY; IRON ABSORPTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAXATION TIME; SEX DIFFERENCE; VERBAL MEMORY; WHITE MATTER; WORKING MEMORY;

AGED; AGING; ATTENTION; BRAIN; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE PROTEINS; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RELAXATION; SEX CHARACTERISTICS; TRANSFERRIN; VERBAL LEARNING;

EID: 79956032674     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.22     Document Type: Article

References (105)

1. Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, Cortes M et al (2008). Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59: 43-55. (Pubitemid 351905863)
2. Alexander GE, DeLong MR, Strick PL (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9: 357-381. (Pubitemid 16055790)
3. Amieva H, Le Goff M, Millet X, Orgogozo JM, Peres K, Barberger-Gateau P et al (2008). Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Ann Neurol 64: 492-498.
4. Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D et al (2002). Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of Florida brain bank. Alzheimer Dis Assoc Disord 16: 203-212. (Pubitemid 35434796)
5. Bartzokis G (2009). Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol Aging. doi:10.1016/j. neurobiolaging.2009.08.007.
6. Bartzokis G, Aravagiri M, Oldendorf WH, Mintz J, Marder SR (1993). Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn Reson Med 29: 459-464. (Pubitemid 23112748)
7. Bartzokis G, Cummings JL, Markham CH, Marmarelis PZ, Treciokas LJ, Tishler TA et al (1999). MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 17: 213-222. (Pubitemid 29053180)
8. Bartzokis G, Lu P, Tishler TA, Peters DG, Kosenko A, Barrall KA et al (2010). Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men. J Alzheimers Dis 20: 333-341.
9. Bartzokis G, Lu PH, Mintz J (2007a). Human brain myelination and amyloid beta deposition in Alzheimer's disease. Alzheimers Dement 3: 122-125. (Pubitemid 46613474)
10. Bartzokis G, Lu PH, Tishler TA, Fong SM, Oluwadara B, Finn JP et al (2007b). Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem Res 32: 1655-1664. (Pubitemid 47428858)
11. Bartzokis G, Mintz J, Sultzer D, Marx P, Herzberg JS, Phelan CK et al (1994). In vivo MR evaluation of age-related increases in brain iron. AJNR Am J Neuroradiol 15: 1129-1138. (Pubitemid 24184373)
12. Bartzokis G, Sultzer D, Cummings BJ, Holt LE, Hance DB, Henderson VW et al (2000). In vivo evaluation of brain iron in Alzheimer's disease and normal controls using magnetic resonance imaging. Arch Gen Psychiatry 57: 47-53. (Pubitemid 30035658)
13. Bartzokis G, Tishler TA, Lu PH, Villablanca P, Altshuler LL, Carter M et al (2007c). Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 28: 414-423. (Pubitemid 46177391)
14. Bartzokis G, Tishler TA, Shin I-S, Lu PH, Cummings JL (2004). Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. In: LeVine S, Connor J, Schipper H (eds). Redox-active Metals in Neurological Disorders Ann NY Acad Sci 1012: 224-236. (Pubitemid 38453528)
15. Battig K, Rosvold HE, Mishkin M (1960). Comparison of the effects of frontal and caudate lesions on delayed response and alternation in monkeys. J Comp Physiol Psychol 53: 400-404.
16. Bouras C, Giannakopoulos P, Good PF, Hsu A, Hof PR, Perl DP (1997). A laser microprobe mass analysis of brain aluminum and iron in dementia pugilistica: comparison with Alzheimer's disease. Eur Neurol 38: 53-58. (Pubitemid 27283080)
17. Braak H, Braak E (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82: 239-259.
18. Braak H, Braak E, Yilmazer D, de Vos RA, Jansen EN, Bohl J (1996). Pattern of brain destruction in Parkinson's and Alzheimer's diseases. J Neural Transm 103: 455-490.
19. Bulte JW, Miller GF, Vymazal J, Brooks RA, Frank JA (1997). Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths. Magn Reson Med 37: 530-536. (Pubitemid 27146831)
20. Burdo JR, Simpson IA, Menzies S, Beard J, Connor JR (2004). Regulation of the profile of iron-management proteins in brain microvasculature. J Cereb Blood Flow Metab 24: 67-74. (Pubitemid 38021270)
21. Cahill CM, Lahiri DK, Huang X, Rogers JT (2008). Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases. Biochim Biophys Acta 1790: 615-628.
22. Carlson ES, Magid R, Petryk A, Georgieff MK (2008). Iron deficiency alters expression of genes implicated in Alzheimer disease pathogenesis. Brain Res 1237: 75-83.
23. Carlson ES, Tkac I, Magid R, O'Connor MB, Andrews NC, Schallert T et al (2009). Iron is essential for neuron development and memory function in mouse hippocampus. J Nutr 139: 672-679.
24. Chen H, Lukas TJ, Du N, Suyeoka G, Neufeld AH (2009). Dysfunction of the retinal pigment epithelium with age: increased iron decreases phagocytosis and lysosomal activity. Invest Ophthalmol Vis Sci 50: 1895-1902.
25. Chen-Roetling J, Chen L, Regan RF (2009). Minocycline attenuates iron neurotoxicity in cortical cell cultures. Biochem Biophys Res Commun 386: 322-326.
26. Chorover SL, Gross CG (1963). Caudate nucleus lesions: behavioral effects in the rat. Science 141: 826-827.
27. Connor JR, Lee SY (2006). HFE mutations and Alzheimer's disease. J Alzheimers Dis 10: 267-276. (Pubitemid 44763997)
28. Constantinidis C, Procyk E (2004). The primate working memory networks. Cogn Affect Behav Neurosci 4: 444-465. (Pubitemid 40342893)
29. Cook CI, Yu BP (1998). Iron accumulation in aging: modulation by dietary restriction. Mech Ageing Dev 102: 1-13. (Pubitemid 28256904)
30. Coppus AM, Evenhuis HM, Verberne GJ, Visser FE, Eikelenboom P, van Gool WA et al (2010). Early age at menopause is associated with increased risk of dementia and mortality in women with Down syndrome. J Alzheimers Dis 19: 545.
31. De Lima MN, Dias CP, Torres JP, Dornelles A, Garcia VA, Scalco FS et al (2007). Reversion of age-related recognition memory impairment by iron chelation in rats. Neurobiol Aging 29: 1052-1059.
32. Deibel MA, Ehmann WD, Markesbery WR (1996). Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci 143: 137-142. (Pubitemid 26402800)
33. Delis DC, Kramer JH, Kaplan E, Ober BA (1987). California Verbal Learning Test. Psychological Corporation: San Antonio, TX.
34. Den Heijer T, Geerlings MI, Hoebeek FE, Hofman A, Koudstaal PJ, Breteler MM (2006). Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. Arch Gen Psychiatry 63: 57-62. (Pubitemid 43037469)
35. Ding B, Chen KM, Ling HW, Sun F, Li X, Wan T et al (2009). Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease. J Magn Reson Imaging 29: 793-798.
36. Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K et al (2010). Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142: 857-867.
37. Floyd RA, Carney JM (1993). The role of metal ions in oxidative processes and aging. Toxicol Ind Health 9: 197-214. (Pubitemid 23216388)
38. Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF et al (2000). Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 54(11 Suppl 5): S10-S15. (Pubitemid 30390599)
39. Friedman A (1994). Old-onset Parkinson's disease compared with young-onset disease: clinical differences and similarities. Acta Neurol Scand 89: 258-261. (Pubitemid 24159037)
40. Georgieff MK (2008). The role of iron in neurodevelopment: fetal iron deficiency and the developing hippocampus. Biochem Soc Trans 36: 1267-1271.
41. Good PF, Perl DP, Bierer LM, Schmeidler J (1992). Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann Neurol 31: 286-292.
42. Gossuin Y, Muller RN, Gillis P (2004). Relaxation induced by ferritin: a better understanding for an improved MRI iron quantification. NMR Biomed 17: 427-432. (Pubitemid 39549420)
43. Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, Ogg RJ et al (2005). Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 23: 1-25. (Pubitemid 40269946)
44. Hallgren B, Sourander P (1958). The effect of age on the non-haemin iron in the human brain. J Neurochem 3: 41-51.
45. Halliwell B, Gutteridge JMC (1985). Oxygen radicals and the nervous system. Trends Neurosci 8: 22-26. (Pubitemid 15171404)
46. Halliwell B, Gutteridge JMC (1988). Iron as biological pro-oxidant. ISI Atlas Sci Biochem 1: 48-52.
47. Hider RC, Ma Y, Molina-Holgado F, Gaeta A, Roy S (2008). Iron chelation as a potential therapy for neurodegenerative disease. Biochem Soc Trans 36: 1304-1308.
48. House MJ, St Pierre TG, Milward EA, Bruce DG, Olynyk JK (2010). Relationship between brain R(2) and liver and serum iron concentrations in elderly men. Magn Reson Med 63: 275-281.
49. Kastman EK, Willette AA, Coe CL, Bendlin BB, Kosmatka KJ, McLaren DG et al (2010). A calorie-restricted diet decreases brain iron accumulation and preserves motor performance in old rhesus monkeys. J Neurosci 30: 7940-7947.
50. Kaur D, Peng J, Chinta SJ, Rajagopalan S, Di Monte DA, Cherny RA et al (2006a). Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age. Neurobiol Aging 28: 907-913. (Pubitemid 46589736)
51. Kaur D, Rajagopalan S, Chinta S, Kumar J, Di Monte D, Cherny RA et al (2006b). Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration. Brain Res 1140: 188-194. (Pubitemid 46356293)
52. Kell DB (2009). Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics 2: 2.
53. Klintworth GK (1973). Huntington's chorea - morphologic contributions of a century. In: Barbeau A, Paulson GW, Chase TN (eds). Advances in Neurology, Vol 1: Huntington's Chorea, 1872-1972. Raven Press: New York. pp 353-368.
54. Kotzbauer PT, Trojanowsk JQ, Lee VM (2001). Lewy body pathology in Alzheimer's disease. J Mol Neurosci 17: 225-232. (Pubitemid 33063526)
55. Kraemer HC, Yesavage JA, Taylor JL, Kupfer D (2000). How can we learn about developmental processes from cross-sectional studies, or can we? Am J Psychiatry 157: 163-171. (Pubitemid 30080893)
56. Landau SM, Lal R, O'Neil JP, Baker S, Jagust WJ (2009). Striatal dopamine and working memory. Cereb Cortex 19: 445-454.
57. Lavados M, Guillon M, Mujica MC, Rojo LE, Fuentes P, Maccioni RB (2008). Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron. J Alzheimers Dis 13: 225-232. (Pubitemid 352038527)
58. Lee SY, Patton SM, Henderson RJ, Connor JR (2007). Consequences of expressing mutants of the hemochromatosis gene (HFE) into a human neuronal cell line lacking endogenous HFE. FASEB J 21: 564-576. (Pubitemid 46213503)
59. Lehmann DJ, Schuur M, Warden DR, Hammond N, Belbin O, Kolsch H et al (2010). Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2010.07.018.
60. Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM (2004). Striatal contributions to working memory: a functional magnetic resonance imaging study in humans. Eur J Neurosci 19: 755-760. (Pubitemid 38241314)
61. Li L, Fang CJ, Ryan JC, Niemi EC, Lebron JA, Bjorkman PJ et al (2010). Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. Proc Natl Acad Sci USA 107: 3505-3510.
62. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM et al (2000). Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 54(11 Suppl 5): S4-S9. (Pubitemid 30390598)
63. Ma L, Wang W, Zhao M, Li M (2008). Foot-shock stress-induced regional iron accumulation and altered iron homeostatic mechanisms in rat brain. Biol Trace Elem Res 126: 204-213.
64. Maaroufi K, Had-Aissouni L, Melon C, Sakly M, Abdelmelek H, Poucet B et al (2009). Effects of prolonged iron overload and low frequency electromagnetic exposure on spatial learning and memory in the young rat. Neurobiol Learn Mem 92: 345-355.
65. Mandel SA, Amit T, Kalfon L, Reznichenko L, Weinreb O, Youdim MB (2008). Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG). J Alzheimers Dis 15: 211-222.
66. Massie HR, Aiello VR, Williams TR (1985). Iron accumulation during development and ageing of Drosophila. Mech Ageing Dev 29: 215-220. (Pubitemid 15128566)
67. Massie HR, Aiello VR, Williams TR (1993). Inhibition of iron absorption prolongs the life span of Drosophila. Mech Ageing Dev 67: 227-237.
68. Miech RA, Breitner JC, Zandi PP, Khachaturian AS, Anthony JC, Mayer L (2002). Incidence of AD may decline in the early 90s for men, later for women: the Cache County Study. Neurology 58: 209-218. (Pubitemid 34084209)
69. Mitchell RM, Lee SY, Simmons Z, Connor JR (2009). HFE polymorphisms affect cellular glutamate regulation. Neurobiol Aging doi:10.1016/j. neurobiolaging.2009.05.016.
70. Moalem S, Percy ME, Andrews DF, Kruck TP, Wong S, Dalton AJ et al (2000). Are hereditary hemochromatosis mutations involved in Alzheimer disease? AM J Med Genet 93: 58-66. (Pubitemid 30350273)
71. Morris CM, Candy JM, Oakley AE, Bloxham CA, Edwardson JA (1992). Histochemical distribution of non-haem iron in the human brain. Acta Anat (Basel) 144: 235-257.
72. Njajou OT, Alizadeh BZ, Aulchenko Y, Zillikens MC, Pols HA, Oostra BA et al (2006). Heritability of serum iron, ferritin and transferrin saturation in a genetically isolated population, the Erasmus Rucphen Family (ERF) Study. Hum Hered 61: 222-228. (Pubitemid 44357219)
73. Pankhurst Q, Hautot D, Khan N, Dobson J (2008). Increased levels of magnetic iron compounds in Alzheimer's disease. J Alzhei-mers Dis 13: 49-52. (Pubitemid 351365627)
74. Pantelatos A, Fornadi F (1993). Clinical features and medical treatment of Parkinson's disease in patient groups selected in accordance with age at onset. Adv Neurol 60: 690-697.
75. Peterson LR, Peterson MJ (1959). Short-term retention of individual verbal items. J Exp Psychol 58: 193-198.
76. Pfefferbaum A, Adalsteinsson E, Rohlfing T, Sullivan EV (2009). MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. Neuroimage 47: 493-500.
77. Raber J, Huang Y, Ashford JW (2004). ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 25: 641-650. (Pubitemid 38686487)
78. Rajendran R, Minqin R, Ynsa MD, Casadesus G, Smith MA, Perry G et al (2009). A novel approach to the identification and quantitative elemental analysis of amyloid deposits-insights into the pathology of Alzheimer's disease. Biochem Biophys Res Commun 382: 91-95.
79. Reitan R, Wolfson D (1985). The Halstead-Reitan Neuropsycholo-gical Test Battery. Neuropsychology Press: Tucson, AZ.
80. Roth JA, Singleton S, Feng J, Garrick M, Paradkar PN (2010). Parkin regulates metal transport via proteasomal degradation of the 1B isoforms of divalent metal transporter 1 (DMT1). J Neurochem 113: 454-464.
81. Sampietro M, Caputo L, Casatta A, Meregalli M, Pellagatti A, Tagliabue J et al (2001). The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease. Neurobiol Aging 22: 563-568. (Pubitemid 32607740)
82. Schmidt AT, Waldow KJ, Grove WM, Salinas JA, Georgieff MK (2007). Dissociating the long-term effects of fetal/neonatal iron deficiency on three types of learning in the rat. Behav Neurosci 121: 475-482. (Pubitemid 47445100)
83. Shoham S, Youdim MB (2002). The effects of iron deficiency and iron and zinc supplementation on rat hippocampus ferritin. J Neural Transm 109: 1241-1256.
84. Siddappa AM, Georgieff MK, Wewerka S, Worwa C, Nelson CA, Deregnier RA (2004). Iron deficiency alters auditory recognition memory in newborn infants of diabetic mothers. Pediatr Res 55: 1034-1041. (Pubitemid 38661797)
85. Simpson EH, Kellendonk C, Kandel E (2010). A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron 65: 585-596.
86. Singh A, Isaac AO, Luo X, Mohan ML, Cohen ML, Chen F et al (2009). Abnormal brain iron homeostasis in human and animal prion disorders. PLoS Pathog 5: e1000336.
87. Smith MA, Harris PL, Sayre LM, Perry G (1997). Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 94: 9866-9868. (Pubitemid 27408156)
88. Smith MA, Zhu X, Tabaton M, Liu G, McKeel Jr DW, Cohen ML et al (2010). Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J Alzheimers Dis 19: 363-372.
89. Squire LR, Zola-Morgan S (1991). The medial temporal lobe memory system. Science 253: 1380-1386. (Pubitemid 21917285)
90. Sullivan JL (1989). The iron paradigm of ischemic heart disease [see comments]. Am Heart J 117: 1177-1188.
91. Thompson CM, Markesbery WR, Ehmann WD, Mao YX, Vance DE (1988). Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology 9: 1-7.
92. Valle A, Silvestri E, Moreno M, Chambery A, Oliver J, Roca P et al (2008). Combined effect of gender and caloric restriction on liver proteomic expression profile. J Proteome Res 7: 2872-2881.
93. Vinet J, Lemieux P, Tamburri A, Tiesinga P, Scafidi J, Gallo V et al (2010). Subclasses of oligodendrocytes populate the mouse hippocampus. Eur J Neurosci 31: 425-438.
94. Vymazal J, Brooks RA, Baumgarner C, Tran V, Katz D, Bulte JW et al (1996a). The relation between brain iron and NMR relaxation times: an in vitro study. Magn Reson Med 35: 56-61. (Pubitemid 26017919)
95. Vymazal J, Brooks RA, Patronas N, Hajek M, Bulte JW, Di Chiro G (1995a). Magnetic resonance imaging of brain iron in health and disease. J Neurol Sci 134(Suppl): 19-26.
96. Vymazal J, Hajek M, Patronas N, Giedd JN, Bulte JW, Baumgarner C et al (1995b). The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration. J Magn Reson Imaging 5: 554-560.
97. Vymazal J, Zak O, Bulte JW, Aisen P, Brooks RA (1996b). T1 and T2 of ferritin solutions: effect of loading factor. Magn Reson Med 36: 61-65. (Pubitemid 26196532)
98. Wechsler D (1981). Wechsler Adult Intelligence Scale-Revised. Psychological Corporation: San Antonio.
99. Wechsler D (1997). Wechsler Adult Intelligence Scale-III: Manual. 3rd edn. Psychological Corporation: San Antonio.
100. Whitfield JB, Cullen LM, Jazwinska EC, Powell LW, Heath AC, Zhu G et al (2000). Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet 66: 1246-1258. (Pubitemid 30468782)
101. Whitfield JB, Treloar S, Zhu G, Powell LW, Martin NG (2003). Relative importance of female-specific and non-female-specific effects on variation in iron stores between women. Br J Haematol 120: 860-866. (Pubitemid 36315112)
102. Xu J, Knutson MD, Carter CS, Leeuwenburgh C (2008). Iron accumulation with age, oxidative stress and functional decline. PLoS One 3: e2865.
103. Yao B, Li TQ, Gelderen P, Shmueli K, de Zwart JA, Duyn JH (2009). Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. Neuroimage 44: 1259-1266.
104. Zecca L, Casella L, Albertini A, Bellei C, Zucca FA, Engelen M et al (2008). Neuromelanin can protect against iron mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease. J Neurochem 106: 1866-1875.
105. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004). Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5: 863-873. (Pubitemid 39482155)